BillionToOne, Inc. Class A Common Stock (BLLN)

Price$86.97

Favorite Metrics

Price vs S&P 500 (4W)-4.98%

Market Capitalization$3.65B

P/E Ratio (Annual)489.81x

All Metrics

P/CF (Annual)148.45x

Book Value / Share (Quarterly)$10.48

Price vs S&P 500 (YTD)-7.08%

Gross Margin (TTM)68.32%

Net Profit Margin (TTM)2.44%

EPS (TTM)$0.18

10-Day Avg Trading Volume0.41M

EPS Excl Extra (TTM)$0.18

EPS (Annual)$0.35

ROI (Annual)1.36%

Gross Margin (Annual)68.32%

Cash / Share (Quarterly)$10.83

P/E Basic Excl Extra (TTM)489.81x

Revenue Growth QoQ (YoY)-37.05%

P/E Normalized (Annual)489.81x

ROA (Last FY)1.18%

EBITD / Share (TTM)$0.36

Operating Margin (TTM)5.25%

Cash Flow / Share (Annual)$0.34

P/B Ratio7.60x

P/B Ratio (Quarterly)7.80x

Net Income / Employee (Annual)$0

Net Interest Coverage (TTM)10.09x

EPS Incl Extra (Annual)$0.35

Current Ratio (Annual)11.69x

Quick Ratio (Quarterly)11.21x

3-Month Avg Trading Volume0.28M

EV / Free Cash Flow (Annual)205.61x

P/E Incl Extra (TTM)489.81x

Revenue / Employee (TTM)$0

P/S Ratio (Annual)11.97x

Asset Turnover (Annual)0.48x

52-Week High$138.70

EPS Excl Extra (Annual)$0.35

Quick Ratio (Annual)11.21x

13-Week Price Return-15.83%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)11.69x

Enterprise Value$3,222.464

Revenue / Employee (Annual)$0

Pretax Margin (Annual)2.54%

Cash / Share (Annual)$10.83

3-Month Return Std Dev78.82%

Net Income / Employee (TTM)$0

ROE (Last FY)1.55%

EPS Basic Excl Extra (Annual)$0.35

EV / Free Cash Flow (TTM)205.61x

Total Debt / Equity (Quarterly)0.14x

EPS Incl Extra (TTM)$0.18

P/S Ratio (TTM)11.97x

Revenue / Share (Annual)$14.37

Forward P/E183.37x

P/E Ratio (TTM)489.81x

Year-to-Date Return-2.94%

5-Day Price Return0.93%

EPS Normalized (Annual)$0.35

Net Profit Margin (Annual)2.44%

Month-to-Date Return0.62%

EBITD / Share (Annual)$0.73

Operating Margin (Annual)5.25%

LT Debt / Equity (Annual)0.12x

P/CF (TTM)148.45x

P/E Excl Extra (TTM)489.81x

LT Debt / Equity (Quarterly)0.12x

EPS Basic Excl Extra (TTM)$0.18

P/B Ratio (Annual)7.80x

Pretax Margin (TTM)2.54%

Book Value / Share (Annual)$10.48

Price vs S&P 500 (13W)-18.70%

Beta0.79x

P/FCF (Annual)232.95x

Revenue / Share (TTM)$7.75

52-Week Low$61.96

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.15

4.21

About

BillionToOne Inc develops precision diagnostic tests using its proprietary Quantitative Counting Templates technology to enable ultrasensitive DNA analysis. The company offers non-invasive prenatal screening and cancer monitoring solutions designed to provide greater accuracy and cost-effectiveness than traditional genetic testing. BillionToOne serves two large markets—prenatal screening and oncology—where demand for improved diagnostics continues to grow.